by Daniel X. Thomas
EP 3 666 797 B1 relates to antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9 (PCSK9) and methods of using and making the antigen binding proteins.
The case is interesting not only as is a decision taken by a Section of the Central Division, but an opposition is going on in parallel at the EPO for the patent at stake and for the patent resulting from a first divisional application.
by Daniel X. Thomas
EP 2 568 724 relates to a “Radio Communication Device and Radio Communication Method”
Brief outline of the case
The claimant has introduced an infringement action before the CFI LD Mannheim.
A counterclaim for revocation has been filed by the alleged infringer.
The chairman and rapporteur has issued an order relating to the procedure,
by Daniel X. Thomas
EP 1 993 350 B1 relates to gene modified brown mushrooms for commercial production. Specific strains were deposited under various ATCC Accession Numbers.
Brief outline of the case
Following opposition before the EPO by two companies, the patent was maintained in amended form. The OD’s decision was not appealed.
by Daniel X. Thomas
EP 2 713 879 B1 relates to a continuous glucose monitoring system.
Brief outline of the case
The proprietor Abbott Diabetes Care Inc. has requested a PI at The Hague LD of the UPC against Sibio Technology Limited and Umedwings Netherlands B.V as it considered the patent infringed by Sibio/Umedwings.
by Daniel X. Thomas
The CD-Paris Section had issued an order (ORD_591040/2023) refusing a stay of proceedings in view of a parallel opposition at the EPO. This order was commented in the present blog.
In an order issued on 28.05.2024, the CoA refused as well the stay of the proceedings.
The only difference in the outline of the case is that an appeal was filed by the proprietor on the refusal of the stay decided by the CD-Paris Section.